Table 3. Baseline Characteristics for Males and Females in the EURODIAB and EDC population.
MALES | FEMALES | ||||||||
---|---|---|---|---|---|---|---|---|---|
EURODIAB | EDC | EURODIAB | EDC | P-Value | |||||
Variable | N=1126 | % | N=304 | % | N=1202 | % | N=299 | % | |
Age at study entry | 0.0010a 0.0001b |
||||||||
Mean (sd) | 32.1 [9.8] | 27.1 [7.6] | 32.2[9.6] | 27.3[7.9] | |||||
Median | 30.8 | 26.6 | 31.1 | 26.6 | |||||
Range | 15-60.7 | 8.5-45.5 | 15.2-59.7 | 8.0-48.0 | |||||
Age at onset of diabetes | 0.0001a 0.0001b |
||||||||
Mean (sd) | 17.4[8.0] | 8.0{4.2] | 18.2[8.1] | 8.4[3.9] | |||||
Median | 17.4 | 8.1 | 18.1 | 8.5 | |||||
Range | 0.3-35.4 | 0.7-15.6 | 0.1-35.6 | 0.3-15.9 | |||||
Diabetes Duration | 0.0001a 0.0001b |
||||||||
Mean (sd) | 14.7[9.2] | 19.1 [7.3] | 13.9[8.9] | 18.9[7.5] | |||||
Median | 13.4 | 18.4 | 12.8 | 17.9 | |||||
Range | 1.0-46.5 | 7.7-37.4 | 1.0-56.0 | 7.7-35.3 | |||||
BMI (kg/m2) | 0.031a 0.11b |
||||||||
Mean (sd) | 23.3[2.9] | 23.6[3.1] | 23.6[2.6] | 23.5[3.4] | |||||
Median | 23 | 23.7 | 23.5 | 22.8 | |||||
Range | 16.1-36.3 | 13.9-33.1 | 15.6-34.3 | 15.1-37.6 | |||||
Waist Hip ratio | 0.0001a 0.0001b |
||||||||
Mean (sd) | 0.8[0.1 | 0.9[0.05] | 0.9[0.08] | 08[.1] | |||||
Median | 0.8 | 0.9 | 0.9 | 0.8 | |||||
Range | 0.5-2.0 | 0.8-1.1 | .6-1.3 | .7-1.0 | |||||
Total Cholesterol | 0.0001a 0.0003b |
||||||||
Mean (sd) | 210.8[43.6] | 187.8[42.3] | 200.5[42.9] | 191.7[39.8] | |||||
Median | 205.7 | 182 | 196.4 | 184 | |||||
Range | 105.6-478.7 | 111-391 | 89.3-474.9 | 107-371 | |||||
HDLc | 0.0001a 0.0001b |
||||||||
Mean (sd) | 63.1 [16.9] | 49.5[9.8] | 53.4[14.8] | 58.5[12.9] | |||||
Median | 61.5 | 48.7 | 52.2 | 57.2 | |||||
Range | 16.2-143.1 | 28.1-91.7 | 10.4-155.1 | 26.3-113 | |||||
LDLc | 0.0001a 0.0001b |
||||||||
Mean (sd) | 130.4[39.1] | 117.1 [36.6] | 127.4[37.0] | 112.6[30.9] | |||||
Median | 124.7 | 111.6 | 124.2 | 109 | |||||
Range | 35.9-375.3 | 47-295.3 | 29.4-278.1 | 34.2-236.4 | |||||
NonHDLc | 0.0002a 0.0001b |
||||||||
Mean (sd) | 147.7[44.9] | 138.3[42.9] | 147[43.5] | 133.2[40.5] | |||||
Median | 140 | 131.2 | 142.1 | 125.5 | |||||
Range | 5.8-442.8 | 61.0-345.9 | 30.5-414.9 | 51.6-336.1 | |||||
Total Chol/HDLc | 0.0001a 0.0001b |
||||||||
Mean (sd) | 3.6[1.4] | 3.9[1.2] | 4.0[1.6] | 3.4[1.1] | |||||
Median | 3.3 | 3.7 | 3.7 | 3.2 | |||||
Range | 1.0-20.5 | 2.2-8.9 | 1.3-21.6 | 1.9-10.6 | |||||
Systolic Bp | 0.26a 0.0001b |
||||||||
Mean (sd) | 117.5[16.8] | 116.3[15.1] | 122.7[16.4] | 109.4[13.7] | |||||
Median | 115 | 113.5 | 121 | 107 | |||||
Range | 61-209 | 76-188 | 78-192 | 77-169 | |||||
Diastolic Bp | 0.09a 0.0001b |
||||||||
Mean (sd) | 73.8[11.0] | 74.9[10.9] | 76.1 [11.2] | 70.1 [10.2] | |||||
Median | 73 | 75 | 75 | 69 | |||||
Range | 36-108 | 44-118 | 32-112 | 49-114 | |||||
Fibrinogen | 0.0001a 0.07b |
||||||||
Mean (sd) | 340[100] | 274.3[85.9] | 305.7[92.4] | 300.5[89.8] | |||||
Median | 333 | 255 | 297 | 280 | |||||
Range | 31-770 | 130-700 | 86-822 | 130-680 | |||||
Albumin excretion rate | 0.0001a 0.0001b |
||||||||
<20 | 802 | 71.2% | 155 | 51.0% | 780 | 64.9% | 178 | 59.5% | |
20-200 | 209 | 18.6% | 78 | 25.7% | 261 | 21.7% | 61 | 20.4% | |
200+ | 73 | 6.5% | 68 | 22.4% | 99 | 8.2% | 58 | 19.4% | |
Antihypertensive medications | 0.16a 0.62b |
||||||||
Yes | 88 | 7.8% | 30 | 9.9% | 101 | 8.4% | 22 | 7.4% | |
No | 1033 | 91.7% | 257 | 84.5% | 1093 | 90.9% | 269 | 90.0% |
EDC vs EURODIAB males
EDC vx EURODIAB females
LDLc=Low Density Lipoprotein
HDLc=High Density Lipoprotein
SBP=Systolic Blood Pressure
DBP=Diastolic Blood Pressure
BMI=Body Mass Index
WBC=White Blood Cell Count